case_images: PMC6196891_01
case_images: Hemoglobin concentration before and after Sirolimus therapy.
case_images: CRIPE2018-7654278.001.jpg
case_images: PMC6196891_01_CRIPE2018-7654278.001.jpg
case_images: fig1
case_images: Within 2 months of initiating sirolimus therapy, she experienced cessation of hematochezia and melena, and her hemoglobin has since remained above 11 g/dl (Figure 1).